Possibia

298

Last Update Posted: 2005-08-17

Recruiting has ended

All Genders

accepted

21 Years-50 Years

0 Estimated Participants

No Expanded Access

Interventional Study

Does not accept healthy volunteers

Buprenorphine Combination Tablet Feasibility - 1

The purpose of this study is to determine target dose range of buprenorphine/naloxone combination tablet that provides therapeutic response in opiate addicts with low to moderate dependence, and to identify appropriate initial induction dose in opiate addicts with low to moderate dependence."

Eligibility

Relevant conditions:

Opioid-Related Disorders

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.

locations

Contact Information

Overall Contact

No valid contacts available

Data sourced from ClinicalTrials.gov